CLASS ACTION UPDATE for SRNE, CLNY and WFC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Back to Newsroom
Mentioned in this Article

CLASS ACTION UPDATE for SRNE, CLNY and WFC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Wednesday, July 15, 2020 3:30 PM
Share this article now
Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / July 15, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

SRNE Shareholders Click Here: https://www.zlk.com/pslra-1/sorrento-therapeutics-inc-information-request-form?prid=7965&wire=1
CLNY Shareholders Click Here: https://www.zlk.com/pslra-1/colony-capital-inc-loss-submission-form?prid=7965&wire=1
WFC Shareholders Click Here: https://www.zlk.com/pslra-1/wells-fargo-company-loss-submission-form?prid=7965&wire=1

* ADDITIONAL INFORMATION BELOW *

Sorrento Therapeutics, Inc. (NASDAQ:SRNE)

SRNE Lawsuit on behalf of: investors who purchased May 15, 2020 - May 22, 2020
Lead Plaintiff Deadline: July 27, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/sorrento-therapeutics-inc-information-request-form?prid=7965&wire=1

According to the filed complaint, during the class period, Sorrento Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's initial finding of "100% inhibition" in an in vitro virus infection will not necessarily translate to success or safety in vivo, or in person; (ii) the Company's finding was not a "cure" for COVID-19; and (ii) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Colony Capital, Inc. (NYSE:CLNY)

CLNY Lawsuit on behalf of: investors who purchased August 9, 2019 - May 7, 2020
Lead Plaintiff Deadline: July 27, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/colony-capital-inc-loss-submission-form?prid=7965&wire=1

According to the filed complaint, during the class period, Colony Capital, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Colony's sale of its industrial real estate portfolio and the bifurcation of Colony Credit Real Estate's portfolio were foreseeably likely to negatively impact Colony's financial and operating results; (ii) certain of Colony's remaining portfolio companies carried unsustainable levels of debt secured by hotels and healthcare-related properties and were thus at a significant risk of default; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Wells Fargo & Company (NYSE:WFC)

WFC Lawsuit on behalf of: investors who purchased April 5, 2020 - May 5, 2020
Lead Plaintiff Deadline: August 3, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/wells-fargo-company-loss-submission-form?prid=7965&wire=1

According to the filed complaint, during the class period, Wells Fargo & Company made materially false and/or misleading statements and/or failed to disclose that: (i) Wells Fargo planned to, and did, improperly allocate government-backed loans under the Paycheck Protection Program ("PPP"), and/or had inadequate controls in place to prevent such misallocation; (ii) the foregoing foreseeably increased the Company's litigation risk with respect to PPP allocation, as well as increased regulatory scrutiny and/or potential enforcement actions; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington, D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
http://www.zlk.com

SOURCE: Levi & Korsinsky, LLP

Levi & Korsinsky, LLP
Back to Newsroom
Copyright 2020 © ACCESSWIRE. All rights reserved. Privacy Policy  |  Terms and Conditions
Drop us a line: